Medical/Pharmaceuticals

Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma

Results of this MD Anderson study were recently published in Cancers and indicate the relevance of enumeration of Circulating Tumor Cells (CTCs) with the minimally invasive liquid biopsy-based CELLSEARCH® system to gain significantly earlier information, compared to standard imaging techniques, o...

2023-10-03 20:00 1937

DrinkAid Marks Its Third Anniversary with an Exclusive Partnership with Singapore's Top Artistic Talent -- Tobyato, Jaeyelle, and JONT

SINGAPORE, Oct. 3, 2023 /PRNewswire/ -- DrinkAid, Singapore's pioneering health supplement brand that alleviates the side effects of alcohol, marks its third anniversary with an exclusive partnership withSingapore's top artistic talent — Tobyato, Jaeyelle, and JONT.  The limited edition boxes, r...

2023-10-03 09:00 2514

Waters Corporation Collaborates with University of San Agustin to Establish the Philippines' First Mass Spectrometry Imaging Center

News Summary: * Using Waters SYNAPT™ High-Definition Mass Spectrometer (HDMS), scientists at the University of San Agustin aspire to become a regional research hub for natural medicine drug discovery. * Scientists will use the SYNAPT HDMS equipped with MALDI and DESI imaging technologies to ...

2023-10-03 08:00 1752

3B Scientific acquires Wallcur

HAMBURG, Germany, Oct. 3, 2023 /PRNewswire/ -- 3B Scientific, a leading manufacturer and marketer of medical simulation products and anatomical models for healthcare education, announces today its acquisition of Wallcur LLC, a prominent provider of healthcare simulation products. This acquisition...

2023-10-03 04:44 1879

Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan

FAIRFIELD, N.J., Oct. 2, 2023 /PRNewswire/ -- Vela Diagnostics announced today a research collaboration with SRL Inc, a premier Japanese healthcare service company. This partnership aims to facilitate the distribution of Vela Diagnostics' cutting-edge molecular diagnostic solutions inJapan. Esta...

2023-10-02 22:16 2615

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

EAST RUTHERFORD, N.J, Oct. 2, 2023 /PRNewswire/ -- Cambrex today announced the completion of its$38 million capacity expansion at its small molecule active pharmaceutical ingredient (API) manufacturing facility inHigh Point, North Carolina. This expansion doubles the facility's manufacturing capa...

2023-10-02 20:51 1858

Advancing Cancer Treatment: Leo Cancer Care and THERYQ Collaborate on Innovative FLASHDEEP Patient Positioning

PEYNIER, France, Oct. 2, 2023 /PRNewswire/ -- The collaboration between Leo Cancer Care and THERYQ brings together the extensive expertise of both organizations to create an integrated solution that promises to revolutionize the treatment of deep-seated tumors. Leveraging cutting-edge technology ...

2023-10-02 20:31 1600

MedAlliance Acquired by Cordis for up to USD 1.135 Billion

GENEVA, Switzerland, Oct. 2, 2023 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of$35M and a 2023 upfront closing payment of $200M, together with regulatory achievement milestones of up to$125M and commercial milestones of up ...

2023-10-02 20:27 7741

ZEISS and Boehringer Ingelheim join forces to develop early detection of eye diseases and prevent vision loss

JENA, Deutschland and INGELHEIM, Deutschland, Oct. 2, 2023 /PRNewswire/ -- ZEISS Medical Technology and Boehringer Ingelheim announce today a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vis...

2023-10-02 20:00 1523

SIBIONICS to Make Debut at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)

SHENZHEN, China, Oct. 2, 2023 /PRNewswire/ -- The 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from October 2nd to 6th, 2023, in Hamburg, Germany. Making its debut at this prestigious event, Shenzhen Sibionics Technology Co., Ltd. (hereinaft...

2023-10-02 16:24 2608

MedAlliance Acquired by Cordis for USD 1.135 Billion

GENEVA, Oct. 2, 2023 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of$35M and a 2023 upfront closing payment of$200M, together with regulatory achievement milestones of up to$125M and commercial milestones of up to $775M throu...

2023-10-02 11:44 2388

Rimegepant is Now Available in Hong Kong, the First Market in Asia, for Migraine Management

HONG KONG, Sept. 29, 2023 /PRNewswire/ -- Pfizer announced the availability of Rimegepant inHong Kong, the first market in Asia, a calcitonin gene-related peptide (CGRP) receptor antagonist for migraine management.[1],[2] There are approximately 12.5% of people living with migraine inHong Kong[3]...

2023-09-29 17:03 2817

#UseHeart movement rallies for change as heart disease continues to claim most lives

GENEVA, Sept. 29, 2023 /PRNewswire/ -- This World Heart Day, the World Heart Federation (WHF) is urging all sectors and citizens to join forces and take down cardiovascular disease (CVD) from its "number one killer" position.

2023-09-29 16:04 2264

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Statistically significant secondary endpoints showed improvements in depressive symptoms and sleep. BNC210 was well-tolerated with a safety prof...

2023-09-29 12:13 2198

Cutting-edge cancer imaging tool allows doctors to efficiently adapt radiotherapy treatment

First patient treated on radiotherapy system equipped with HyperSight imaging solution at Icon Cancer Centre MELBOURNE, Australia, Sept. 29, 2023 /PRNewswire/ -- An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for pati...

2023-09-29 10:06 1955

Academic Conference on "Research on Female Reproductive Health in International Perspective" Successfully Concluded

HONG KONG, Sept. 29, 2023 /PRNewswire/ -- On September 22nd, the academic conference on "Female Reproductive Health Research in International Perspective", organized by Hong Kong Research Institute of Modern Chinese Medicine for Reproductive Anti-aging(HKMCMRA), was successfully concluded in Hong...

2023-09-29 09:00 2967

Ascletis Announces Positive Interim Data from the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure

HANGZHOU and SHAOXING, China, Sept. 29, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces positive interim data from the Phase IIb expansion cohort (the "Expansion Cohort") of subcutaneously administered PD-L1 antibody ASC22 (Envafolimab) for functional cure of ch...

2023-09-29 08:10 2629

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

82.4% of patients without prior CAR-T achieving Complete Response (CR) or better ROCKVILLE, Md. and SUZHOU, China, Sept. 29, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-qualit...

2023-09-29 08:00 2716

ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study

SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCQB: ALRTF), a diabetes management company, announces the patent application titledMethod and System of Monitoring a Diabetes Treatment Plan("Predictive A1c") has been granted in Singapore and has rec...

2023-09-28 20:28 5218

PATIENTS SPEAK UP ABOUT KIDNEY DISEASE

COMMUNITY HEALTH CAMPAIGN "LIVE YOUR WAY" LAUNCHES ACROSS SINGAPORE * Life with kidney disease the focus of new public health campaign * Baxter Healthcare and National Kidney Foundation partner for patients SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- Baxter International, a global medtech leade...

2023-09-28 13:48 2081
1 ... 81828384858687 ... 397